Clinical Report: Late-Onset Hypoglycemia in Extremely Low GA or Birth Weight Infants
Overview
This study investigates the prevalence and risk factors of late-onset hypoglycemia in infants born extremely preterm or with low birth weight.
Background
Late-onset hypoglycemia is a significant concern for preterm infants, particularly those with extremely low gestational age or birth weight. These infants are at heightened risk due to metabolic challenges during their transition from intrauterine to extrauterine life. Understanding the incidence and risk factors associated with late-onset hypoglycemia is crucial.
Data Highlights
No numerical data or trial data was provided in the source material.
Key Findings
Late-onset hypoglycemia is defined as blood glucose < 2.6 mmol/L at postnatal age ≥ 8 days.
Only a few studies have focused on late-onset hypoglycemia in preterm infants after the first week of life.
Infants with hypoglycemia below 2.6 mmol/L show significant deficits in neurodevelopmental outcomes.
The study aims to identify demographic, clinical, and nutritional factors that contribute to late-onset hypoglycemia.
Neurodevelopmental outcomes at a corrected age of 18–24 months will be assessed in the study population.
Clinical Implications
Healthcare providers should monitor blood glucose levels in infants born extremely preterm or with low birth weight, especially after the first week of life.
Conclusion
The investigation into late-onset hypoglycemia in high-risk infants is essential for understanding its implications.
